← Back to directory
Not currently recruitingFunding unknown
- Works count
- 216
- Citation count
- 25,029
- H-index
- 49
- i10-index
- 83
Research interests
Medicine
Biochemistry, Genetics and Molecular Biology
HER2/EGFR in Cancer Research
Melanoma and MAPK Pathways
Cancer Immunotherapy and Biomarkers
Colorectal Cancer Treatments and Studies
Lung Cancer Treatments and Mutations
Publications
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
New England Journal of Medicine · 2019 · 10.1056/nejmoa1904059
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
New England Journal of Medicine · 2018 · 10.1056/nejmoa1716948
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
The Lancet · 2015 · 10.1016/s0140-6736(15)60898-4
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
New England Journal of Medicine · 2014 · 10.1056/nejmoa1408868
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
New England Journal of Medicine · 2014 · 10.1056/nejmoa1406037
Current projects
No projects listed.